U.S. Oil and Gas Stock News

Penumbra (NYSE:PEN) is set to be acquired by Boston Scientific in a US$14.5b deal, following the release of strong quarterly results. The transaction, announced alongside Penumbra's recent earnings report, represents a major consolidation move in the medical device space. The combination brings together Penumbra's interventional therapies with Boston Scientific's broader medical technology portfolio. For you as an investor, this centers on a specialized medical device maker that focuses on...

NANO Nuclear Energy Inc. recently appointed Michael Montecalvo as Licensing Director, bringing over 30 years of experience across the U.S. Navy, commercial nuclear industry, and the U.S. Nuclear Regulatory Commission to lead its licensing strategy and regulatory engagement. By adding a licensing leader who has worked on both sides of the regulatory table, the company is strengthening a core capability for moving its advanced nuclear products toward key milestones. We’ll now examine how...

Sempra (SRE) is back in focus after its latest earnings topped analyst expectations, with Q3 2025 revenue of US$3.2b and adjusted EPS of US$1.11, even as the stock trails its sector. See our latest analysis for Sempra. The share price, now at US$87.36, has slipped over the last quarter with a 6.79% 90 day share price return, even as the 1 year total shareholder return of 10.05% signals steadier long term momentum supported by dividends. If this earnings beat has you looking at other parts of...

Workiva Inc. recently announced the appointment of two veteran finance leaders, former Cisco and Autodesk CFO Scott Herren and former Workday Co-President and CFO Mark Peek, as independent directors, alongside the resignation of director David Mulcahy and the elevation of Suku Radia to Lead Independent Director. The addition of these seasoned former CFOs, each with extensive experience in large-scale software and technology businesses, could meaningfully influence Workiva’s board oversight...

If you are wondering whether Fastly's current share price reflects its real worth, you are not alone. This article will walk through what the numbers actually say about the stock. Fastly's shares last closed at US$8.57, with returns of a 7.4% decline over 7 days, an 18.6% decline over 30 days, a 15.9% decline year to date, a 15.3% decline over 1 year, a 13.2% decline over 3 years and a 91.6% decline over 5 years. These moves may have changed how investors think about its potential and...

Western Alliance Bancorporation’s board recently approved a quarterly cash dividend of US$0.42 per common share and a US$106.25 per share dividend on its 4.250% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A, alongside reporting higher fourth-quarter 2025 net interest income of US$766.2 million and net income of US$286.1 million versus the prior year. The company also completed a US$68.2 million share repurchase of 800,000 shares and absorbed higher net loan charge-offs...

What the latest earnings mean for QCR Holdings (QCRH) QCR Holdings (QCRH) just released full year 2025 results, showing higher net interest income and net income compared with 2024, alongside steady fourth quarter net charge offs and completion of a recent share repurchase tranche. See our latest analysis for QCR Holdings. The earnings beat, steady fourth quarter net charge offs and completion of the buyback each appear to have contributed to strong momentum, with a 30 day share price return...

Univest Financial (UVSP) has drawn fresh attention after reporting fourth quarter and full year 2025 results, as well as confirming its quarterly dividend and updating investors on progress under a long running share repurchase program. See our latest analysis for Univest Financial. Those earnings, dividend and buyback updates sit alongside a solid run in the share price, with a 90 day share price return of 21.25% and a 1 year total shareholder return of 18.64%. This suggests momentum has...

Origin Bancorp, Inc. has reported its fourth quarter and full-year 2025 results, outlined 2026 net interest income growth guidance in the mid- to high single digits, disclosed significantly lower fourth quarter net charge-offs versus the prior quarter, affirmed a US$0.15 quarterly dividend, and completed a US$27.23 million share repurchase tranche covering 2.47% of its shares. An interesting angle for investors is how the combination of improved credit costs, disciplined capital returns, and...

OneStream was recently recognized as a Leader in the IDC MarketScape: Worldwide Enterprise Planning, Budgeting, and Forecasting Applications 2026 Vendor Assessment, reflecting the strength of its AI-enabled Finance platform. This recognition, combined with increasingly positive analyst expectations for its upcoming earnings, reinforces OneStream’s position at the forefront of AI adoption in corporate Finance. Next, we’ll examine how IDC’s endorsement of OneStream’s AI-powered Finance...

Corporación América Airports (CAAP) has drawn investor interest after recent share price moves, with the stock closing at $28.90 and showing contrasting returns over the past week, month, and past 3 months. See our latest analysis for Corporación América Airports. That 2.34% 1 day share price gain sits within a stronger recent trend, with a 30 day share price return of 8.85% and 90 day share price return of 31.90%. The 1 year total shareholder return of 48.51% points to momentum that has...

Monarch Casino & Resort stock overview Monarch Casino & Resort (MCRI) has drawn investor attention after recent share price moves, with the stock last closing at $98.87 alongside solid trailing returns across the past year and the past 3 months. See our latest analysis for Monarch Casino & Resort. The recent 3.54% 1 day share price return and 8.02% 7 day share price return build on steadier gains over the past quarter. Over a 1 year period the total shareholder return is 16.58%, alongside a 5...

In its fourth-quarter 2025 investor letter, Baron Health Care Fund disclosed that it had added Repligen Corporation as a new portfolio holding, citing the company’s strong bioprocessing technology franchise and potential to grow recurring consumable revenues. The fund also highlighted Repligen’s use of AI for real-time drug production monitoring and its opportunity to benefit from pharmaceutical reshoring, framing these as key drivers of its long-term business opportunity. We’ll now examine...

Trinity Capital (TRIN) is back in focus after issuing preliminary fourth quarter 2025 guidance, indicating net investment income of $0.51 to $0.53 per share and reporting that approximately 0.7% of its debt investments are on non-accrual. See our latest analysis for Trinity Capital. The preliminary guidance and low 0.7% non accrual level come as Trinity Capital’s share price sits at US$16.19, with a 30 day share price return of 5.47% and a 90 day gain of 10.89%. The 1 year total shareholder...

Blue Heron launch puts Credo’s AI connectivity story in focus Credo Technology Group Holding (CRDO) has introduced its Blue Heron 224G AI scale-up retimer, a multiprotocol chip built on a 3nm process to support demanding connectivity requirements inside AI data centers. The product is designed to recover 40+dB 224G links across extended cable and backplane distances using UALink, ESUN and Ethernet, giving data center operators more flexibility in how they place GPUs and switch chips. See our...

Virtus Investment Partners (VRTS) has wrapped up FY 2025 with Q4 revenue of US$208.0 million and basic EPS of US$5.25, alongside trailing 12 month revenue of US$852.9 million and EPS of US$20.27, setting a clear marker for its recent performance. Over the past year, the company has seen revenue shift from US$906.9 million to US$852.9 million on a trailing basis. At the same time, trailing 12 month net income moved from US$121.7 million to US$138.4 million, reflecting the mix of pressure and...

Molina Healthcare (NYSE:MOH) reported a large quarterly loss, citing sustained margin pressures and retroactive premium adjustments tied to its California Medicaid business. The company recorded a US$93 million impairment to intangible assets, pointing to financial strain in parts of its portfolio. Molina issued weak guidance for 2026 and significantly revised its credit agreement, including a temporary relaxation of its interest coverage covenant. Molina Healthcare focuses on government...

Why Madrigal Pharmaceuticals Is On Investors’ Radar Madrigal Pharmaceuticals (MDGL) has drawn attention after a recent move in its share price, with the stock up 3.1% over the past day but showing weaker returns over the past month. See our latest analysis for Madrigal Pharmaceuticals. The 3.1% one-day share price gain comes after weaker recent momentum, with a 30-day share price return of a 14.9% decline and a year-to-date share price return of a 19.6% decline. However, the 1-year total...

If you are wondering whether Chesapeake Utilities at around US$129.87 is offering fair value or if you might be paying up for reliability, this article is designed to help you assess that question clearly. The stock has returned 0.9% over the last 7 days, 7.4% over 30 days, 4.5% year to date, 7.4% over 1 year and 40.2% over 5 years, which may have some investors rethinking both its growth potential and its risk profile. Recent coverage of Chesapeake Utilities has focused on its role as a...

Annual results put First Merchants in focus First Merchants (FRME) has captured investor attention after reporting full year 2025 earnings, with higher net interest income and net income, alongside a quarter that included increased net charge offs. See our latest analysis for First Merchants. That annual report appears to have caught the market’s eye, with the share price at US$42.34 and a 90 day share price return of 17.55% alongside a 5 year total shareholder return of 21%. This suggests...

AbbVie has submitted regulatory applications to the FDA and EMA for Rinvoq as a potential systemic treatment for non segmental vitiligo. The filings target a condition where there are currently no approved systemic therapies, highlighting a major unmet medical need. The move could broaden the use of one of AbbVie's key immunology assets beyond its existing indications. For investors following AbbVie, NYSE:ABBV, this update comes with the stock recently closing at $223.43. The company has...

Palomar Holdings (NasdaqGS:PLMR) has completed its acquisition of The Gray Casualty & Surety Company. The company has also secured $450 million in new unsecured financing. The transaction expands Palomar's surety franchise and broadens its geographic footprint. The new financing is intended to support Palomar's operational scale and financial flexibility. Palomar Holdings focuses on specialty insurance, and adding The Gray Casualty & Surety Company gives it a larger presence in the surety...

What Chart Industries’ recent performance data tells you Chart Industries (GTLS) has drawn investor attention after recent share performance data highlighted mixed short term moves alongside stronger multi year returns, prompting closer scrutiny of how current fundamentals line up with the price. See our latest analysis for Chart Industries. At a share price of $207.45, Chart Industries has seen only modest recent share price moves. A 1 year total shareholder return of 5.59% and a 3 year...

Champion Homes (SKY) shares moved after the company reported fourth quarter 2025 results with adjusted earnings and EBITDA above analyst expectations, stronger free cash flow, and net sales growth despite pressure on operating margins. See our latest analysis for Champion Homes. At a share price of $83.59, Champion Homes has seen a 6.65% 7 day share price return and a softer 30 day share price return of 4.03%. The 1 year total shareholder return of 19.53% contrasts with a 5 year total...